Mike McCabe: Short little span of attention

The news of the day used to be reported in extraordinary detail. Contrast that with the 140-character format of bulletins—dubbed “tweets”—that made a present-day social media platform one of the world’s most popular.

Read More »

Mike McCabe: Short little span of attention

The news of the day used to be reported in extraordinary detail. Contrast that with the 140-character format of bulletins—dubbed “tweets”—that made a present-day social media platform one of the world’s most popular.

Read More »

Archeus Technologies, WARF launching clinical trial this year for cancer targeting molecule

Archeus Technologies in Madison and WARF are launching a clinical trial this year for a targeting molecule used in treating prostate cancer.  The organizations yesterday announced the plans to further develop ART-101, a receptor-based targeting molecule developed at UW-Madison’s Advanced Radiotheranostics lab. It’s designed to deliver radioactive isotopes within the

Read More »